Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:592489rdf:typepubmed:Citationlld:pubmed
pubmed-article:592489lifeskim:mentionsumls-concept:C0341628lld:lifeskim
pubmed-article:592489lifeskim:mentionsumls-concept:C0007716lld:lifeskim
pubmed-article:592489lifeskim:mentionsumls-concept:C0596545lld:lifeskim
pubmed-article:592489lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:592489lifeskim:mentionsumls-concept:C1710261lld:lifeskim
pubmed-article:592489pubmed:issue11lld:pubmed
pubmed-article:592489pubmed:dateCreated1978-2-23lld:pubmed
pubmed-article:592489pubmed:abstractTextOral sustained release cephalexin (S-6437) was administered to 24 pediatric patients. Daily dose used was 18 approximately 60 mg/kg, which was divided into two doses and given after breakfast and dinner. The following are the results of the study. Out of 24 patients, 6 showed very good response, 10 good response, 6 fair, 1 poor and 1 unknown, Ratio of effectiveness was 69.6%. Two patients were reluctant to receive the drug and, therefore, they took other drugs. The other 22 patients, however, were easily given. No remarkable side effects due to S-6437 were found. From the above results, it was recognized that S-6437 has good effectiveness and safety, and it is convenient to give to children because the frequency of the drug administration is only twice a day.lld:pubmed
pubmed-article:592489pubmed:languagejpnlld:pubmed
pubmed-article:592489pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:592489pubmed:citationSubsetIMlld:pubmed
pubmed-article:592489pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:592489pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:592489pubmed:statusMEDLINElld:pubmed
pubmed-article:592489pubmed:monthNovlld:pubmed
pubmed-article:592489pubmed:issn0368-2781lld:pubmed
pubmed-article:592489pubmed:authorpubmed-author:BRUCEM AMAlld:pubmed
pubmed-article:592489pubmed:authorpubmed-author:ItoSSlld:pubmed
pubmed-article:592489pubmed:authorpubmed-author:KatoRRlld:pubmed
pubmed-article:592489pubmed:authorpubmed-author:TsuzukiKKlld:pubmed
pubmed-article:592489pubmed:authorpubmed-author:IwayamaSSlld:pubmed
pubmed-article:592489pubmed:issnTypePrintlld:pubmed
pubmed-article:592489pubmed:volume30lld:pubmed
pubmed-article:592489pubmed:ownerNLMlld:pubmed
pubmed-article:592489pubmed:authorsCompleteYlld:pubmed
pubmed-article:592489pubmed:pagination888-92lld:pubmed
pubmed-article:592489pubmed:dateRevised2009-11-11lld:pubmed
pubmed-article:592489pubmed:meshHeadingpubmed-meshheading:592489-H...lld:pubmed
pubmed-article:592489pubmed:meshHeadingpubmed-meshheading:592489-A...lld:pubmed
pubmed-article:592489pubmed:meshHeadingpubmed-meshheading:592489-I...lld:pubmed
pubmed-article:592489pubmed:meshHeadingpubmed-meshheading:592489-C...lld:pubmed
pubmed-article:592489pubmed:meshHeadingpubmed-meshheading:592489-C...lld:pubmed
pubmed-article:592489pubmed:meshHeadingpubmed-meshheading:592489-F...lld:pubmed
pubmed-article:592489pubmed:meshHeadingpubmed-meshheading:592489-M...lld:pubmed
pubmed-article:592489pubmed:meshHeadingpubmed-meshheading:592489-D...lld:pubmed
pubmed-article:592489pubmed:meshHeadingpubmed-meshheading:592489-B...lld:pubmed
pubmed-article:592489pubmed:meshHeadingpubmed-meshheading:592489-A...lld:pubmed
pubmed-article:592489pubmed:meshHeadingpubmed-meshheading:592489-D...lld:pubmed
pubmed-article:592489pubmed:meshHeadingpubmed-meshheading:592489-C...lld:pubmed
pubmed-article:592489pubmed:year1977lld:pubmed
pubmed-article:592489pubmed:articleTitle[Clinical experience with sustained release cephalexin (X-6437) (author's transl)].lld:pubmed
pubmed-article:592489pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:592489pubmed:publicationTypeEnglish Abstractlld:pubmed